Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

May 31, 2005

Study Completion Date

June 30, 2005

Conditions

Encephalitis, Tick-borne

Interventions

BIOLOGICAL

Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Trial Locations (1)

SGS Biopharma Research Unit Stuivenberg, Antwerp